WASHINGTON — Synthetic biology, the industry built around using back-end technologies to engineer the life sciences, has long prided itself on having a quirky, countercultural ethos — and having more fun than those stuffy suits in biotech and pharma. It was just two years ago, after all, that a biohacker CRISPR’d himself on stage at the industry’s big annual conference.
Now, though, the industry is trying to establish its footing here in a town with a culture utterly unlike its own.
Leading companies that print DNA and design microbes just launched the industry’s first lobbying group. On Monday, industry leaders gathered at the White House for a first-of-its-kind summit celebrating the technology. And on Tuesday, they plan to head to Capitol Hill to speak with staffers who work on a House committee focused on science and technology.
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect